Internal medicine

Disease

Population

Family medicine

Gastroenterology

Political science

Steatosis

MEDLINE

Fatty liver

Scopus

Traditional medicine

Medicine

Environmental health

Journal of Hepatology

Non-alcoholic fatty liver disease (NAFLD) is defined as excess hepatic fat accumulation after the exclusion of heavy alcohol use or other secondary causes of steatosis. In 2018, it was estimated that NAFLD affects about the 25% of the world population, with the highest prevalence in South America (32%).1 Worryingly, it has been estimated that liver deaths related to NAFLD will increase by 178% by 2030,1 with no approved drug treatment to date. Thus, NALFD represents a burden to health and economic systems in all societies.

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience